Target type: biologicalprocess
The process of preserving the structure and function of mature myelin. This includes maintaining the compact structure of myelin necessary for its electrical insulating characteristics as well as the structure of non-compact regions such as Schmidt-Lantermann clefts and paranodal loops. This does not include processes responsible for maintaining the nodes of Ranvier, which are not part of the myelin sheath. [GOC:dgh]
Myelin maintenance is a complex and essential process for the proper function of the nervous system. It involves a series of tightly regulated events that ensure the integrity and stability of the myelin sheath, which is a fatty layer that insulates axons and allows for rapid and efficient nerve impulse conduction.
**Myelin Synthesis and Assembly:**
1. **Oligodendrocytes (in the central nervous system) and Schwann cells (in the peripheral nervous system) are responsible for myelin production.** These glial cells differentiate and produce myelin, a multi-layered membrane composed primarily of lipids and proteins.
2. **Myelin formation begins with the wrapping of the myelin sheath around the axon.** This process involves the extension of cell processes from the glial cells and their tight wrapping around the axon.
3. **The myelin sheath is composed of multiple layers of compacted plasma membrane.** These layers are held together by specialized proteins that create a stable and insulating structure.
**Myelin Maintenance and Repair:**
1. **Myelin is a dynamic structure that requires continuous maintenance.** This includes the constant turnover of myelin components, the repair of damaged myelin, and the adaptation of myelin to changes in neuronal activity.
2. **Myelin maintenance involves a complex interplay of molecular signaling pathways and cellular processes.** These processes ensure the proper formation, stability, and repair of myelin.
3. **In case of damage, myelin can be repaired through a process called remyelination.** This involves the recruitment of oligodendrocyte precursor cells or Schwann cells, which differentiate and produce new myelin to replace the damaged sections.
**Factors Affecting Myelin Maintenance:**
1. **Genetic factors:** Mutations in genes involved in myelin formation and maintenance can lead to myelin disorders.
2. **Environmental factors:** Exposure to toxins, inflammation, and oxidative stress can damage myelin and impair its function.
3. **Age:** Myelin maintenance declines with age, contributing to age-related cognitive decline.
4. **Lifestyle factors:** Factors like diet, exercise, and stress can influence myelin health.
**Consequences of Impaired Myelin Maintenance:**
1. **Demyelination:** The loss of myelin can lead to impaired nerve impulse conduction, causing neurological disorders such as multiple sclerosis (MS).
2. **Neurodegenerative diseases:** Disruption of myelin maintenance can contribute to the progression of neurodegenerative diseases, such as Alzheimer's disease.
3. **Cognitive decline:** Impaired myelin function can affect cognitive abilities, memory, and learning.
**In conclusion, myelin maintenance is a vital process for the proper function of the nervous system. It involves a complex interplay of cellular processes, molecular signaling, and environmental factors. Maintaining myelin health is crucial for preventing neurological disorders and preserving cognitive function throughout life.'
"
Protein | Definition | Taxonomy |
---|---|---|
C-X-C chemokine receptor type 4 | A C-X-C chemokine receptor type 4 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P61073] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
zalcitabine | zalcitabine : A pyrimidine 2',3'-dideoxyribonucleoside compound having cytosine as the nucleobase. Zalcitabine: A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy. | pyrimidine 2',3'-dideoxyribonucleoside | antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor |
plerixafor | plerixafor : An azamacrocycle consisting of two cyclam rings connected by a 1,4-phenylenebis(methylene) linker. It is a CXCR4 chemokine receptor antagonist and a hematopoietic stem cell mobilizer. It is used in combination with grulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the perpheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma. plerixafor: a bicyclam derivate, highly potent & selective inhibitor of HIV-1 & HIV-2 | azacycloalkane; azamacrocycle; benzenes; crown amine; secondary amino compound; tertiary amino compound | anti-HIV agent; antineoplastic agent; C-X-C chemokine receptor type 4 antagonist; immunological adjuvant |
benzylaniline | benzylaniline: major metabolite of antazoline; RN given refers to parent cpd | ||
terephthalamide | benzenedicarboxamide | ||
krh 1636 | KRH 1636: structure in first source | ||
amd 8664 | |||
cyclo(d-tyrosyl-arginyl-arginyl-3-(2-naphthyl)alanyl-glycyl) | oligopeptide | ||
amd 070 | mavorixafor: a derivative of AMD3100; a CXCR4 blocker | aminoquinoline | |
wz 811 | |||
tn14003 | TN14003: synthetic antagonist 14-mer peptide inhibiting metastasis in an animal model |